Particle.news
Drug Development Clinical Trials Vaccine Development Clinical Research Drug Discovery Drug Delivery Systems Antibiotics Antibody Development Moderna Fertility Drugs Drug Candidates Drug Formulation AVEO Pharmaceuticals Acquisition Diagnostics Genetic Research Antibiotic Development Cancer Vaccines Research Security Drug Companies Protein Delivery Systems Investment Strategies Monoclonal Antibodies Research and Development Antibiotic Resistance Weight Loss Drugs Vaccine Technology Vaccine Innovation Veterinary Applications Oncology Therapeutic Vaccines Manufacturing Vaccines Cancer Therapies Polilaminina Takeda Pharmaceutical Company Biosanitary Applications AI Models Drug Combinations Antibody Therapeutics AI Applications Cancer Research Research Programs
A same-day collaboration with AbbVie underscores pharma interest in AI-led small-molecule discovery as Iambic readies a potential up-to-$100 million Nasdaq offering.
